CCIA
OYST

Cherry Creek Investment Advisors’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Cherry Creek Investment Advisors’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$56K – 95
2022
Q3 		$56K Hold
10,000
– – 0.05% 89
2022
Q2 		$43K Buy
+10,000
New +$56.9K 0.03% 89

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Cherry Creek Investment Advisors's OYST Position: Q4 2022 in Review

Cherry Creek Investment Advisors sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q4 2022, closing a stake of 10,000 shares — an estimated $56K sold.

Cherry Creek Investment Advisors first reported a position in OYST in Q2 2022 and held it in 2 quarters. The position peaked at $56K in Q3 2022. 53 funds tracked by Wall St. Rank hold OYST as of Q4 2022.

  • Cherry Creek Investment Advisors reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Cherry Creek Investment Advisors sold 10,000 Oyster Point Pharma, Inc. Common Stock shares in Q4 2022, an estimated $56K.
  • Cherry Creek Investment Advisors first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Cherry Creek Investment Advisors's Oyster Point Pharma, Inc. Common Stock position peaked at $56K in Q3 2022.
  • 53 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q4 2022.

Based on Cherry Creek Investment Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.